Profile data is unavailable for this security.
About the company
Humana Inc. is a health and well-being company. The Company's segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, including dental, vision, and other supplemental health and financial protection products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand.
- Revenue in USD (TTM)67.72bn
- Net income in USD2.61bn
- Incorporated1964
- Employees46.00k
- LocationHumana Inc500 W Main StLOUISVILLE 40202United StatesUSA
- Phone+1 (502) 580-1000
- Fax+1 (302) 636-5454
- Websitehttp://www.humana.com/
More ▼
Mergers & acquisitions
| Acquired company | HUM:NYQ since announced | Transaction value |
|---|---|---|
| Enclara Health Inc | 11.73% | -- |
Data delayed at least 15 minutes, as of Aug 04 2020 00:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Davita Inc | 11.52bn | 823.57m | 10.99bn | 65.00k | 13.88 | 4.94 | 6.59 | 0.9538 | 6.29 | 6.34 | 86.55 | 17.66 | 0.5874 | 81.67 | 6.09 | 177,290.40 | 5.31 | 4.47 | 7.88 | 5.80 | 31.00 | 29.49 | 9.04 | 7.13 | 1.33 | 5.54 | 0.7327 | 0.00 | -0.1436 | -2.30 | 14.45 | -0.492 | 3.63 | -- |
| Molina Healthcare, Inc. | 17.68bn | 797.00m | 11.02bn | 10.00k | 14.27 | 5.49 | 12.52 | 0.6231 | 13.02 | 13.02 | 287.31 | 33.83 | 2.43 | -- | 12.55 | 1,768,400.00 | 10.94 | 3.35 | 21.47 | 8.23 | 18.67 | 15.24 | 4.51 | 1.35 | -- | 13.84 | 0.5056 | 0.00 | -10.91 | 11.73 | 4.24 | 63.76 | -13.09 | -- |
| Livongo Health Inc | 206.96m | -45.94m | 13.36bn | 671.00 | -- | 26.52 | -- | 64.58 | -0.5023 | -0.5023 | 2.25 | 5.15 | 0.5506 | 3.91 | 5.03 | 336,520.30 | -12.21 | -- | -13.67 | -- | 73.85 | -- | -22.17 | -- | 10.23 | -- | 0.00 | -- | 148.71 | -- | -65.05 | -- | -- | -- |
| Quest Diagnostics Inc | 7.53bn | 749.00m | 17.46bn | 47.00k | 23.63 | 2.99 | 16.12 | 2.32 | 5.50 | 5.50 | 55.38 | 43.51 | 0.6086 | 38.31 | 6.80 | 160,234.00 | 6.02 | 6.90 | 7.18 | 7.97 | 34.13 | 36.96 | 9.89 | 9.70 | 1.21 | 7.11 | 0.4344 | 34.05 | 2.59 | 0.7708 | 16.13 | 8.75 | 5.37 | 10.45 |
| Laboratory Corp. of America Holdings | 11.47bn | 362.20m | 19.09bn | 65.00k | 53.42 | 2.59 | 20.06 | 1.66 | 3.67 | 3.67 | 117.33 | 75.57 | 0.6448 | 29.71 | 5.39 | 176,530.80 | 2.04 | 4.90 | 2.42 | 5.62 | 27.25 | 29.71 | 3.16 | 7.04 | 1.01 | 6.37 | 0.4609 | 0.00 | 1.95 | 13.96 | -11.29 | 10.01 | 14.48 | -- |
| Centene Corp | 91.58bn | 1.56bn | 36.56bn | 56.60k | 22.09 | 1.46 | 14.66 | 0.3993 | 2.86 | 2.86 | 184.81 | 43.25 | 1.78 | -- | 11.79 | 1,617,951.00 | 3.01 | 3.67 | 4.56 | 6.17 | 18.43 | 17.97 | 1.69 | 1.54 | -- | 6.67 | 0.4002 | 0.00 | 24.16 | 35.14 | 46.78 | 37.58 | 47.94 | -- |
| HCA Healthcare Inc | 50.15bn | 3.34bn | 42.55bn | 210.00k | 12.98 | -- | 6.39 | 0.8485 | 9.70 | 9.70 | 145.36 | -5.28 | 1.07 | 4.48 | 7.51 | 238,790.50 | 8.39 | 9.51 | 11.65 | 12.28 | 83.66 | 83.35 | 7.88 | 7.70 | 0.9487 | 3.79 | 0.982 | 7.36 | 9.98 | 6.82 | 8.31 | 13.33 | 13.83 | -- |
| Humana Inc | 67.72bn | 2.61bn | 52.16bn | 46.00k | 20.26 | 4.22 | 16.41 | 0.7703 | 19.48 | 19.48 | 505.57 | 93.45 | 2.15 | -- | -- | 1,472,087.00 | 8.24 | 6.88 | -- | -- | -- | -- | 3.83 | 3.12 | -- | 14.25 | 0.3967 | 12.92 | 14.01 | 5.99 | 57.20 | 18.74 | 6.87 | 14.34 |
Data as of Aug 04 2020. Currency figures normalised to Humana Inc's reporting currency: US Dollar USD
45.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2020 | 9.86m | 7.46% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2020 | 9.51m | 7.20% |
| Capital Research & Management Co. (International Investors)as of 31 Mar 2020 | 8.35m | 6.32% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 6.44m | 4.87% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 5.82m | 4.40% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2020 | 5.50m | 4.16% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2020 | 4.81m | 3.64% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2020 | 3.70m | 2.80% |
| Renaissance Technologies LLCas of 31 Mar 2020 | 3.53m | 2.67% |
| Wellington Management Co. LLPas of 31 Mar 2020 | 2.22m | 1.68% |
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
